Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Jay Achar

11 ta ish

Médecins sans Frontières, Manson Unit, London, UK

  1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

    James M. Trauer, Jay Achar, Nargiza Parpieva +7

    MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos
    ABI

  2. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Beverley Stringer, Nell Gray +5

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos
    ABI

  3. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos
    ABI

  4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos
    ABI

  5. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    MaqolaTuberculosis Research and EpidemiologyERJ Open Research20201 iqtibos
    ABI

  6. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Shona Horter, Jay Achar, Nell Gray +4

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20201 iqtibos
    ABI

  7. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

    Jay Achar, Catherine Berry, Krzysztof Herboczek +7

    BoshqaTuberculosis Research and EpidemiologyEmerging infectious diseases20150 iqtibos
    ABI

  8. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

    Horacio Gil, Hasmik Margaryan, I. Azamat +8

    MaqolaTuberculosis Research and EpidemiologyTropical Medicine & International Health20210 iqtibos
    ABI

  9. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

    Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

    PreprintTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos
    ABI

  10. A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

    Michael L. Rekart, Phone Thit, Modupe Oluya +14

    Sharh maqolaTuberculosis Research and EpidemiologyIJTLD OPEN20240 iqtibos
    ABI

  11. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

    Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

    Sharh maqolaTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos
    ABI